Filing Details
- Accession Number:
- 0001140361-16-062146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-27 10:55:50
- Reporting Period:
- 2016-04-26
- Filing Date:
- 2016-04-27
- Accepted Time:
- 2016-04-27 10:55:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457518 | First Eagle Value In Biotechnology Master Fund, Ltd. | Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205 | No | No | Yes | No | |
1459688 | 21 April Fund, L.p. | First Eagle Investment Management, Llc 1345 Avenue Of The Americas, 44Th Floor New York NY 10105 | No | No | Yes | No | |
1459708 | 21 April Fund, Ltd. | Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205 | No | No | Yes | No | |
1637141 | First Eagle Holdings, Inc. | 1345 Avenue Of The Americas New York NY 10105 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-04-26 | 5,500,000 | $1.25 | 19,881,546 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents 1,064,843, 3,935,157 and 500,000 shares purchased by 21 April Fund, L.P. ("21 April LP"), 21 April Fund, Ltd. ("21 April Ltd."), and First Eagle Value in Biotechnology Master Fund, Ltd. ("FEVIBM" and, together with 21 April LP and 21 April Ltd., the "Funds"), respectively. First Eagle Investment Management, LLC ("FEIM") is (i) a general partner of 21 April LP, (ii) the registered investment adviser to the Funds, and (iii) a subsidiary of First Eagle Holdings, Inc. ("FEHI"). FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
- Represents 3,062,449, 11,232,153, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.